BTIG Downgrades Globus Medical (GMED) to Neutral on Spine Business Concerns
On Tuesday, May 27, an analyst from BTIG downgraded Globus Medical Inc. (NYSE:GMED) from Buy to Neutral, citing concerns about its Spine business.
Globus Medical Inc (GMED)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Sculptor Capital Daniel S. Och | 2,092,838 | $153,195,742 | +1% | 2.94% |
| 2. | Hawk Ridge Management David Brown | 1,680,075 | $122,981,490 | +1% | 5.81% |
| 3. | Camber Capital Management Stephen Dubois | 1,250,000 | $91,500,000 | +3% | 3.25% |
| 4. | Polar Capital Brian Ashford-Russell And Tim Woolley | 1,050,380 | $76,887,816 | +37% | 0.47% |
| 5. | Driehaus Capital Richard Driehaus | 873,784 | $63,960,989 | +61% | 0.62% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $53.88 | 615 | $33,136.20 | 2,005 | 2020-08-24 | Filing | |
| $47.75 | 690 | $32,947.50 | 1,390 | 2020-07-22 | Filing | |
| $48.20 | 700 | $33,740.00 | 700 | 2020-06-22 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $78.68 | 7,500 | $590,100.00 | 35,384 | 2025-02-28 | Filing | |
| $89.17 | 1,666 | $148,557.22 | 0 | 2025-01-10 | Filing | |
| $88.17 | 12,501 | $1,102,213.17 | 1,666 | 2025-01-10 | Filing | |
| $87.00 | 2,500 | $217,501.50 | 0 | 2024-12-02 | Filing | |
| $85.00 | 6,746 | $573,434.96 | 165,967 | 2024-11-22 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 10,909,082 | $798,544,802 | 0.01% | |
| 2. | 10,723,911 | $784,990,284 | 0.02% | |
| 3. | 7,006,223 | $508,285,945 | 0.28% | |
| 4. | 3,615,523 | $264,656,284 | 0.01% | |
| 5. | 2,801,747 | $205,087,880 | 2.13% |
News See All
Globus Medical, Inc. (NYSE:GMED) Q1 2025 Earnings Call Transcript
Operator: Welcome to the Globus Medical’s First Quarter 2025 Earnings Call. [Operator Instructions].
7 Best Medical Technology Stocks To Buy According To Analysts
The MedTech sector is crucial in healthcare, which concentrates on the creation of medical devices aimed at enhancing disease prevention, diagnosis, and treatment.
Globus Medical, Inc. (NYSE:GMED) Q4 2024 Earnings Call Transcript
Operator: Welcome to the Globus Medical's Fourth Quarter and Full Year 2024 Earnings Call. This time, all lines will be on mute and a Q&A session will be held after the prepared remarks.
10 High Growth Healthcare Stocks to Invest in Now
During lean economic times, investing in healthcare stocks is generally regarded as defensive.
Globus Medical, Inc. (NYSE:GMED) Q3 2024 Earnings Call Transcript
Operator: Welcome to Globus Medical's Third Quarter 2024 Earnings Call. At this time, all lines will be on mute and a Q&A session will be held after the prepared remarks.
8 Most Promising Medical Stocks According to Hedge Funds
The healthcare sector depends on medical technology advancements, particularly devices used in disease prevention, diagnosis, and treatment.
Globus Medical, Inc. (NYSE:GMED) Q2 2024 Earnings Call Transcript
Operator: Welcome to Globus Medical's Second Quarter 2024 Earnings Call. At this time, all lines will be on mute and a Q&A session will be held after the prepared remarks.
Globus Medical, Inc. (NYSE:GMED) Q1 2024 Earnings Call Transcript
Globus Medical, Inc. beats earnings expectations. Reported EPS is $0.72, expectations were $0.55. Globus Medical, Inc.
11 Best Small-Cap Growth Stocks to Invest In
In this piece, we will take a look at the 11 best small-cap growth stocks to invest in.
Billionaire Hedge Funds
